Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis

Heart Rhythm

Volumn 12, Issue 12, 2015, Pages 2488-2498

  Tung, Roderick ^a   Bauer, Brenton ^a   Schelbert, Heinrich ^a   Lynch, Joseph P ^a   Auerbach, Martin ^a   Gupta, Pawan ^a   Schiepers, Christiaan ^a   Chan, Samantha ^a   Ferris, Julie ^a   Barrio, Martin ^a   Ajijola, Olujimi ^a   Bradfield, Jason ^a   Shivkumar, Kalyanam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiomyopathy; Inflammation; Positron emission tomography; Ventricular arrhythmia

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ABLATION THERAPY; ADULT; ARRHYTHMOGENESIS; ARRHYTHMOGENIC INFLAMMATORY CARDIOMYOPATHY; ARTICLE; CARDIOMYOPATHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART PERFUSION; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; COHORT ANALYSIS; COMPLICATION; DIAGNOSTIC IMAGING; INCIDENCE; INFLAMMATION; LYMPH NODE; MULTIMODAL IMAGING; PATIENT REFERRAL; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENCE; INFLAMMATION; LYMPH NODES; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDITIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERRAL AND CONSULTATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84960098564     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.08.014     Document Type: Article

References (35)

1. F. Sacher, U.B. Tedrow, M.E. Field, J.M. Raymond, B.A. Koplan, L.M. Epstein, and W.G. Stevenson Ventricular tachycardia ablation: evolution of patients and procedures over 8 years Circ Arrhythm Electrophysiol 1 2008 153 161
2. I. Kindermann, C. Barth, F. Mahfoud, C. Ukena, M. Lenski, A. Yilmaz, K. Klingel, R. Kandolf, U. Sechtem, L.T. Cooper, and M. Bohm Update on myocarditis J Am Coll Cardiol 59 2012 779 792
3. B.A. Koplan, K. Soejima, K. Baughman, L.M. Epstein, and W.G. Stevenson Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation Heart Rhythm 3 2006 924 929
4. A. Thachil, J. Christopher, B.K. Sastry, K.N. Reddy, V.K. Tourani, A. Hassan, B.S. Raju, and C. Narasimhan Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function J Am Coll Cardiol 58 2011 48 55
5. S. Ishimaru, I. Tsujino, T. Takei, E. Tsukamoto, S. Sakaue, M. Kamigaki, N. Ito, H. Ohira, D. Ikeda, N. Tamaki, and M. Nishimura Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
6. R. Tung, N. Mathuria, Y. Michowitz, R. Yu, E. Buch, J. Bradfield, R. Mandapati, I. Wiener, N. Boyle, and K. Shivkumar Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia Circ Arrhythm Electrophysiol 5 2012 264 272
7. G.M. Felker, W. Hu, J.M. Hare, R.H. Hruban, K.L. Baughman, and E.K. Kasper The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients Medicine (Baltimore) 78 1999 270 283
8. J.W. Mason, J.B. O'Connell, A. Herskowitz, N.R. Rose, B.M. McManus, M.E. Billingham, and T.E. Moon A clinical trial of immunosuppressive therapy for myocarditis: the Myocarditis Treatment Trial Investigators N Engl J Med 333 1995 269 275
9. A.L. Caforio, S. Pankuweit, E. Arbustini, and et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 2636 2648 2648a-2648d
10. P.P. Liu, and J.W. Mason Advances in the understanding of myocarditis Circulation 104 2001 1076 1082
11. C. Kawai From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future Circulation 99 1999 1091 1100
12. S. Kumar, C. Barbhaiya, K. Nagashima, and et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation Circ Arrhythm Electrophysiol 8 2015 87 93
13. R. Kandolin, J. Lehtonen, M. Graner, J. Schildt, K. Salmenkivi, S.M. Kivisto, and M. Kupari Diagnosing isolated cardiac sarcoidosis J Intern Med 270 2011 461 468
14. D. Jefic, B. Joel, E. Good, F. Morady, H. Rosman, B. Knight, and F. Bogun Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry Heart Rhythm 6 2009 189 195
15. O. Manabe, K. Yoshinaga, H. Ohira, T. Sato, I. Tsujino, A. Yamada, N. Oyama-Manabe, A. Masuda, K. Magota, M. Nishimura, and N. Tamaki Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis Ann Nucl Med 28 2014 656 663
16. H.H. Hsia, D.J. Callans, and F.E. Marchlinski Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia Circulation 108 2003 704 710
17. A. Ichinose, H. Otani, M. Oikawa, K. Takase, H. Saito, H. Shimokawa, and S. Takahashi MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function AJR Am J Roentgenol 191 2008 862 869
18. D.G. Dechering, S. Kochhauser, K. Wasmer, and et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy Heart Rhythm 10 2013 158 164
19. B. Philips, S. Madhavan, C.A. James, and et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear Circ Arrhythm Electrophysiol 7 2014 230 236
20. S. Hasegawa, H. Kusuoka, K. Maruyama, T. Nishimura, M. Hori, and J. Hatazawa Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers J Am Coll Cardiol 43 2004 224 233
21. H. Yamaguchi, S. Hasegawa, J. Yoshioka, T. Uehara, K. Hashimoto, H. Kusuoka, T. Kuzuya, M. Hori, and T. Nishimura Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy Ann Nucl Med 14 2000 33 38
22. H. Yamagishi, N. Shirai, M. Takagi, M. Yoshiyama, K. Akioka, K. Takeuchi, and J. Yoshikawa Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET J Nucl Med 44 2003 1030 1036
23. G. Youssef, E. Leung, I. Mylonas, and et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2012 241 248
24. R. Blankstein, M. Osborne, M. Naya, and et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis J Am Coll Cardiol 63 2014 329 336
25. N. Tahara, A. Tahara, Y. Nitta, N. Kodama, M. Mizoguchi, H. Kaida, K. Baba, M. Ishibashi, N. Hayabuchi, J. Narula, and T. Imaizumi Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis JACC Cardiovasc Imaging 3 2010 1219 1228
26. Y. Naruse, Y. Sekiguchi, A. Nogami, and et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis Circ Arrhythm Electrophysiol 7 2014 407 413
27. J.E. Parrillo, R.E. Cunnion, S.E. Epstein, M.M. Parker, A.F. Suffredini, M. Brenner, G.L. Schaer, S.T. Palmeri, R.O. Cannon 3rd, D. Alling, and et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy N Engl J Med 321 1989 1061 1068
28. A. Frustaci, M.A. Russo, and C. Chimenti Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study Eur Heart J 30 2009 1995 2002
29. C.Z. Chiu, S. Nakatani, G. Zhang, T. Tachibana, F. Ohmori, M. Yamagishi, M. Kitakaze, H. Tomoike, and K. Miyatake Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis Am J Cardiol 95 2005 143 146
30. S. Nakahara, R. Tung, R.J. Ramirez, Y. Michowitz, M. Vaseghi, E. Buch, J. Gima, I. Wiener, A. Mahajan, N.G. Boyle, and K. Shivkumar Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia J Am Coll Cardiol 55 2010 2355 2365
31. I. Liuba, D.S. Frankel, M.P. Riley, and et al. Scar progression in patients with nonischemic cardiomyopathy and ventricular arrhythmias Heart Rhythm 11 2014 755 762
32. H. Ohira, I. Tsujino, S. Ishimaru, N. Oyama, T. Takei, E. Tsukamoto, M. Miura, S. Sakaue, N. Tamaki, and M. Nishimura Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 2008 933 941
33. Y. Choi, R.C. Brunken, R.A. Hawkins, S.C. Huang, D.B. Buxton, C.K. Hoh, M.E. Phelps, and H.R. Schelbert Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans Eur J Nucl Med 20 1993 308 318
34. P. Iozzo, P. Chareonthaitawee, M. Di Terlizzi, D.J. Betteridge, E. Ferrannini, and P.G. Camici Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans Am J Physiol Endocrinol Metab 282 2002 E1163 E1171
35. R. Kandolin, J. Lehtonen, J. Airaksinen, and et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study Circulation 131 2015 624 632